On Jan. 06, Lockhart Kimber D divested U.S. $1,294,829 in shares of 1Life Healthcare Inc.. The CTO sold 30,000 shares at a price per share of $43.16. The transaction decreased this specific insider’s holdings to 70,434 shares worth around $3.0 million at present.
BTIG Research launched its 1Life Healthcare Inc. [ONEM] rating to the equivalent of a Neutral, in a research note dated January 07, 2021. Some new analysts also started their coverage, with BTIG Research’s analysts assigning the shares to “a Neutral” rating in a research note to investors issued in early January. Meanwhile, Credit Suisse had launched its coverage on ONEM with “an Outperform”, in a research note produced for clients October 30, 2020. In addition, there was a new coverage from Deutsche Bank on October 14, 2020. The research firm rated ONEM “a Buy”.
Is 1Life Healthcare Inc. [NASDAQ:ONEM] a Good Buy Right Now?
It should be noted that ONEM technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 88% Buy in the past month. Data from 1Life Healthcare Inc.’s Trend Spotter indicated that the signals were Weakening. The stock current average is 0.88 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 1.34 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 1.55 million shares.
ONEM Price Performance
On Wall Street, 1Life Healthcare Inc. [NASDAQ:ONEM] finished Thursday’s session up 0.64% at $42.56. The stock went up to $44.27 at the same session while its lowest single day price was $41.25. In the last five days, it saw a fall of about -2.14%, 1Life Healthcare Inc. shares dropped by almost -2.50% since the beginning of the year. However, the share price has dropped to as low as -5.15% below its one year high. The 50-day SMA achieved is $36.24 while the 200-day SMA is $31.22. Volume dropped to 1.03 million from 1.19 million in the previous session.
ONEM Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 41.12 level, and in case of violation of this particular level, it will cause more drop to 39.67 level. On the upper level, 45.71 is still the key resistance. The stock may increase to the subsequent resistance at 44.14. The Relative Strength Index (RSI) pinned on the 14-day chart is 65.35, implying a neutral technical stance while the MACD stands at -0.02, meaning price will decrease in the next trading period. Percent R indicator moved to 32.82%, implying low price movement. Stochastic %K at 70.53% suggest holding the stock.
What is the short interest in 1Life Healthcare Inc.?
Short interest in the 1Life Healthcare Inc. stock has surged, increasing by 1.43 million shares to total 9.11 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 10.54 million, data from Yahoo Finance shows. The decrease of -15.7% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 10.07% of the overall float for the stock.
1Life Healthcare Inc.’s Biggest Shareholders: Who Owns 1Life Healthcare Inc. [ONEM]?
Filings by Fidelity Management & Research Co showed that the firm now holds a total of 15,059,203 shares or roughly 11.32% of the outstanding ONEM shares. This means their shares have increased by 4,839,598 from the 15,059,203 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, The Vanguard Group, Inc. updated stake is worth $208,424,857. Details in the latest 13F filings reveal that BlackRock Fund Advisors acquired their 271.66% stake valued at $162,578,669 while Gilder, Gagnon, Howe & Co. LLC added theirs at $136,617,877. During the last quarter, BlackRock Fund Advisors raised 3,615,297 of its shares in 1Life Healthcare Inc. while Gilder, Gagnon, Howe & Co. LLC bought 1,729,761 shares. The Fidelity’s holdings currently number 4,037,127 shares at $171820125.12. According to the firm’s last 13F report, Maverick Capital Ltd. shares in the company at filing stood at 3,955,185 shares, roughly $130,006,931.
ONEM Earnings Forecast For The Current Quarter
1Life Healthcare Inc. [ONEM] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $106.96M and an earnings per share of -$0.14 for Dec 2020. Looking further ahead, the company is expected to report revenue of $108.34M at an EPS of -$0.16 for Mar 2021. The estimates represent upside of 30.20% and 31.80% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
ONEM Earnings Estimates For The Current Year
For the financial year, 1Life Healthcare Inc. [NASDAQ:ONEM] is expected to bring in revenue of $365.38M. The returns are nearly $89.12 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at -0.85, higher than that of FY19 by $1.99. Estimates put this year’s earnings growth at 70.10%, 31.80% for the next, and at an annual -56.02% over the next 5-year period. As for sales, forecasts are for an increase of 32.30% in the current fiscal year and a further 30.20% over the following year.
What are analyst thoughts on 1Life Healthcare Inc.?
Looking forward to the 1Life Healthcare Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for 1Life Healthcare Inc. stock at $42.00 within the next 12 months, which represents almost -1.33 per cent growth from its previous closing price of $42.56. The highest analysts’ target for 1Life Healthcare Inc. stock projections is $50.00 and the lowest one is $32.00. Still, 13 analysts sharing their consensus rating for ONEM stock in 2021 agree that it is an Overweight.